-
Company Profile
![]()
Huma Therapeutics Ltd – Company Profile
Huma Therapeutics Ltd (Huma Therapeutics) is a global healthcare company that provides enterprise mobile healthcare solutions. The company through its hospital at home technology enables greater access to care for patients from any location and improves efficiency for clinicians by collecting real-world patient data remotely. It also develops regulated Software as a Medical Device (SaMD) solutions. Huma Therapeutics platform delivers targeted educational content to better track and manage patients' health. The company serves hospitals, patients and clinics. It operates in...
Add to Basket -
State Power Invt – Huma County Wind Farm 100 MW – Heilongjiang
Equip yourself with the essential tools needed to make informed and profitable decisions with our State Power Invt – Huma County Wind Farm 100 MW – Heilongjiang report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:Dive...
-
Product Insights
Huma Therapeutics Ltd Pipeline Insight and Competitive Landscape, 2023
Huma Therapeutics Ltd (Huma Therapeutics), formerly Humaforhealth Ltd, is a global healthcare company that provides enterprise mobile healthcare solutions. The company through its hospital at home technology enables greater access to care for patients from any location and improves efficiency for clinicians by collecting real-world patient data remotely. It also develops regulated Software as a Medical Device (SaMD) solutions. Huma Therapeutics platform delivers targeted educational content to better track and manage patients' health. The company serves hospitals, patients and clinics....
-
Company Insights
Bayer AG – Digital Transformation Strategies
Bayer implemented a five-year global IT strategy to drive its digital business transformation by aligning itself to emerging technologies like cloud, IoT, and AI among others. The annual ICT spending of Bayer was estimated at $2.3 billion in 2022. A major share of this spending is earmarked for acquiring hardware, network and communications, and software from vendors. Bayer is a life science company engaged in research, development, manufacture, and supply of products in healthcare and agriculture. Total ICT Spending 2022...
-
Sector Analysis
Digital Biomarkers Market Size, Share and Trends Analysis by Region, Product Type (Wearable Application, Mobile Application, Portables), End-user (Healthcare Companies and Services, Others), and Segment Forecast, 2022-2027
The digital biomarkers market size was valued at US$2.32 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 25.7% during 2022-2027. The key to the digital biomarkers market growth has been the aging population and rise in chronic diseases, increasing investments and funding to develop digital biomarkers, and increasing role of digital biomarkers in clinical trials. Additionally, key strategic partnerships and mergers and acquisitions are expected to accelerate market growth. Over the forecast...
-
Product Insights
Remote Patient Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Remote patient monitoring devices are used to retrieve and transmit data through a wireless system to a monitoring station or a physician’s office for further analysis and interpretation. The Remote Patient Monitoring pipeline market research report provides comprehensive information about the Remote Patient Monitoring pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Thematic Analysis
![]()
Future Unicorn Predictions – Spot Tomorrow’s Winners Today
This report compendium consists of 5 reports that are based on GlobalData’s proprietary ranking of 10,000 top startups. The list has been compiled using GlobalData’s Quant-based Startup Scorecard tool combined with proprietary Machine Learning (ML) algorithms. The tool accurately predicts promising future Unicorns (Startups predicted to be valued at US$1bn or more) by analyzing the crucial indicators of previously identified Unicorns. Use GlobalData’s intelligence to help you to spot tomorrow’s winners today.
-
Thematic Analysis
![]()
Remote Patient Monitoring – Opportunities for Pharma – Thematic Research
Remote patient monitoring (RPM) relies on digital health technologies and connected devices to record vital signs and relay data and information to patients, careers, and physicians or healthcare teams. RPM enables clinicians to track patients in real time through a clinician dashboard or directly within a patient’s electronic health record (EHR), allowing timely intervention if necessary. RPM also gives patients more control over their health and a sense of empowerment, while improving health outcomes. The use of RPM has gained...
-
Company Insights
Future Artificial Intelligence (AI) Unicorns
This report analyzes the top 50 Artificial Intelligence startups from the “GlobalData Startup Scorecard” that has the potential to become unicorns (valuation more than US$1bn) based on the GlobalData’s Unicorn Prediction Model. The model is based on a proprietary machine learning (ML) algorithm which analyzes millions of data points related to venture capital (VC) investment activity for startups and can predict future unicorns.
-
Company Insights
Bayer AG – Enterprise Tech Ecosystem Series
Bayer implemented a five-year global IT strategy to drive its digital business transformation by aligning itself to new technologies like cloud, IoT, and AI among others, and using them to create various digital platforms. Bayer is digitally transforming its internal operations to improve productivity and efficiency and have cost-effective functional areas. For example, it deployed a digital twin-based scheduling program at its pharma manufacturing site in Italy, bringing improvements in its quality-control lab, and transforming it into a smart factory....
-
Case Studies
Coronavirus Disease 2019 (COVID-19) Impact on Digital Biomarkers Market
The ongoing COVID-19 crisis has seen social distancing and lockdown measures implemented around the world, which has had widespread effects on the healthcare industry, particularly in the ways that patients and healthcare professionals can safely interact while minimizing risks of viral transmission. Remote patient monitoring and the collection of digital biomarkers by connected devices has emerged as an important approach to support patients and healthcare systems during the pandemic. This case study assesses how connected devices and digital biomarkers can...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.